表紙
市場調査レポート

瘻孔:世界の治験レビュー

Fistula Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 240572
出版日 ページ情報 英文 53 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
瘻孔:世界の治験レビュー Fistula Global Clinical Trials Review, H2, 2015
出版日: 2015年12月09日 ページ情報: 英文 53 Pages
概要

当レポートでは、世界の瘻孔治療薬の臨床試験について調査し、 地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 瘻孔
    • レポートガイダンス
  • 臨床試験: 地域別
  • 臨床試験: 国別
    • 臨床試験に寄与している主要国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中東およびアフリカ
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験: 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要: 主要企業
      • Anterogen Co., Ltd.
      • Cellerix, S.A.
      • Ipsen Inc.
      • Ocera Therapeutics.
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • Vanderbilt University
      • Hospital Universitario La Paz
      • Leiden University Medical Center
      • Hospital Universitario Virgen de la Arrixaca
      • Sint Franciscus Gasthuis
      • Ottawa Hospital Research Institute
      • The Oregon Clinic
      • Hospital Universitario Central de Asturias
      • Christian Medical College
      • Queen Mary, University of London
      • Mount Sinai School of Medicine
      • University of Patras
      • Akershus University Hospital
      • Cliniques Universitaires Saint-Luc
      • Legacy Health System
      • Imperial College London
      • University of Hull
  • 5つの主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3046CTIDB

GlobalData's clinical trial report, "Fistula Global Clinical Trials Review, H2, 2015" provides an overview of Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Fistula to Other Diseases Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Fistula to Other Diseases Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Fistula Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Fistula
      • Oct 22, 2015: Phase I Trial of Cytori Cell Therapy for Inflammatory Bowel Disease Published
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Fistula Therapeutics, Global, Clinical Trials by Region, 2015*
  • Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Fistula Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Fistula Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Fistula to Other Diseases Clinical Trials, G7 Countries (%), 2015*
  • Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Fistula to Other Diseases Clinical Trials, E7 Countries (%), 2015*
  • Fistula Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Fistula Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Fistula Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Fistula Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Fistula Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Fistula Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Fistula Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Fistula to Other Diseases Clinical Trials, G7 Countries (%), 2015*
  • Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Fistula to Other Diseases Clinical Trials, E7 Countries (%), 2015*
  • Fistula Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Fistula Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Fistula Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Fistula Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top